Topics
Astrocytoma | Outcomes | WHO grade 2 or 3 and 3 IDH1/2 wt
Home > Publications > Topics > Astrocytoma > Outcomes > WHO grade 2 or 3 and 3 IDH1/2 wt
Keric N, Krenzlin H, Kalasauskas D, Freyschlag CF, Schnell O,
Misch M, von der Brelie C, Gempt J, Krigers A, Wagner A, Lange F,
Mielke D, Sommer C, Brockmann MA, Meyer B, Rohde V, Vajkoczy P,
Beck J, Thomé C, Ringel F.
Treatment
outcome of IDH1/2 wildtype CNS WHO grade 4 glioma histologically
diagnosed as WHO grade II or III astrocytomas.
J
Neurooncol. 2024 Feb 7. doi:
10.1007/s11060-024-04585-7. PMID:
38326661. Observational
study.
ˍ